CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-03 | Robb Gary Charles Chief Business Officer | Option exercise 10b5-1 | +3,037 | $3.29 | $10K | 23,156 |
| 2025-01-03 | Robb Gary Charles Chief Business Officer | Option exercise · Stock option (right to buy) 10b5-1 | −3,037 | 0 | ||
| 2025-01-02 | Maduck Sean See Remarks | Option exercise 10b5-1 | +20,000 | $3.88 | $78K | 105,318 |
| 2025-01-02 | Maduck Sean See Remarks | Sale 10b5-1 | −20,000 | $50.39 | $1.0M | 85,318 |
| 2025-01-02 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 21,986 | ||
| 2025-01-02 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +5,000 | $11.35 | $57K | 13,759 |
| 2025-01-02 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −5,000 | $50.39 | $252K | 8,759 |
| 2025-01-02 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −5,000 | 4,167 | ||
| 2025-01-02 | Robb Gary Charles Chief Business Officer | Option exercise 10b5-1 | +11,000 | $3.29 | $36K | 31,119 |
| 2025-01-02 | Robb Gary Charles Chief Business Officer | Sale 10b5-1 | −11,000 | $50.50 | $556K | 20,119 |
| 2025-01-02 | Robb Gary Charles Chief Business Officer | Option exercise · Stock option (right to buy) 10b5-1 | −11,000 | 3,037 | ||
| 2025-01-01 | BAKER G LEONARD JR Director | Gift | −0 | 3,308,303 | ||
| 2024-12-27 | WILSON JAMES N Director | Gift | −7,800 | 1,306,226 | ||
| 2024-12-10 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +2,200 | $12.13 | $27K | 2,200 |
| 2024-12-10 | Swisher Daniel N JR Director | Sale 10b5-1 | −2,200 | $59.46 | $131K | 0 |
| 2024-12-10 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 10,600 | ||
| 2024-12-02 | Guyer William Chief Development Officer | Shares withheld for taxes | −309 | $57.68 | $18K | 5,487 |
| 2024-12-02 | Maduck Sean See Remarks | Shares withheld for taxes | −295 | $57.68 | $17K | 84,788 |
| 2024-12-02 | Maduck Sean See Remarks | Grant or award | +265 | $59.21 | $16K | 85,053 |
| 2024-12-02 | Maduck Sean See Remarks | Grant or award | +265 | 85,318 |
Page 33 of 61 · 1,220 trades